Genetic code

Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction

Retrieved on: 
Wednesday, October 5, 2022
Technology, Biotechnology, Health, Environmental Issues, Professional Services, Environmental, Social and Governance (ESG), Other Philanthropy, Philanthropy, Other Science, Environment, Other Technology, Research, Genetics, Science, Genetic code, Houston Zoo, Disease, RNA transfection, Life, Elephas, EEHV, Virology, Genetic engineering, Research, List of life sciences, Baylor University, Mammoth, Multimedia, VGP, Partnership, Technology, Biodiversity, Department, Health, African bush elephant, CRISPR, Genetics, Elephant, New product development, Vertebrate Genomes Project, Death, Baylor College of Medicine, Hunting, African elephant, Barn, Colossal

Colossal Biosciences, a breakthrough genetic engineering and de-extinction company, accelerates efforts to end elephant extinction on Earth.

Key Points: 
  • Colossal Biosciences, a breakthrough genetic engineering and de-extinction company, accelerates efforts to end elephant extinction on Earth.
  • Colossal will lead the development of novel treatments and a vaccine to prevent the deadly disease and protect as many elephants as possible - both in zoos and in their natural habitats.
  • Colossal and Dr. Lings lab will accelerate milestones in three phases, including the development and rollout of a protein subunit vaccine, the development of an mRNA vaccine, and the development of a monoclonal antibody treatment.
  • Were thrilled to advance science to benefit both existing and future generations of elephants and mammoths, said Justin Quinn, Colossal Director of Product Development.

Most-Read Study Reveals Importance of the Microbiome for Covid-19 Susceptibility

Retrieved on: 
Wednesday, September 21, 2022
International Lyme and Associated Diseases Society, American College of Gastroenterology, Therapy, Charlotte Convention Center, Infection, Bacteroides, American College, COVID-19, Virus, Alzheimer's disease, Association, Severe acute respiratory syndrome coronavirus 2, Clostridioides difficile infection, Dysbiosis, Immunity, Patient, Physician, 2021 Essex County Council election, Frontiers, CRO, Solution, Bacteria, ILADS, Fungus, NGS, Research, Conference, PCR, Genetic code, NIH, Disease, FMT, Pharmaceutical industry, Vaccine, Dietary supplement, Medical device, Bifidobacterium, Faecalibacterium, Neurology

VENTURA, Calif., Sept. 21, 2022 /PRNewswire/ -- ProgenaBiome, a Ventura-based genetic sequencing research lab, published a study in April, 2022, which has since then been listed as one of the Most Read Articles on BMJ Open Gastro. It offers an explanation for why Covid-19 patients experience varying levels of severity in symptoms, from asymptomatic to severe – as well as why some are not infected at all upon exposure. Researchers discovered an inverse association between disease severity and both bacterial diversity and Bifidobacterium and Faecalibacterium abundance.

Key Points: 
  • "This study, sponsored by the Microbiome Research Foundation , further supports the hypothesis I have always believed: the microbiome is a critical piece of the puzzle for many health conditions," said Dr. Sabine Hazan, co-author of the study.
  • "This study demonstrates the importance of a strong microbiome," Dr. Hazan added.
  • To support its mission, please support the Microbiome Research Foundation , a 501(c)(3) non-profit organization, dedicated to helping patients with diseases of the gut flora (microbiome).
  • For more information: https://progenabiome.com
    The Microbiome Research Foundation, is a 501(c)(3) non-profit organization, dedicated to helping patients with diseases of the gut flora.

Current Biologics names chief executive

Retrieved on: 
Tuesday, September 20, 2022
Therapy, Merck KGaA v. Integra Lifesciences I, Ltd., Health, Biologics license application, Child, Hospital, FDA, MD, Disease, Army, LLC, CGMP, Cincinnati Children's Hospital Medical Center, News, Integra, Clarkson University, Rutgers University, Patient, Johnson & Johnson, CEO, Consultant, Biopharmaceutical, Contract, Good manufacturing practice, Clinical trial, Leadership, Doctor of Philosophy, U.S. News & World Report, Biotechnology, Research, Multimedia, Genetic code, CTI, Education, MiMedx, View, Pharmaceutical industry, Management, Hochuli

CINCINNATI, Sept. 20, 2022 /PRNewswire/ --The board of Current Biologics has selected Tom Hochuli as chief executive officer of the startup company, which is focused on providing cell and gene therapy manufacturing and development services to the biotechnology and pharmaceutical industries. Current Biologics was established as a joint venture of Cincinnati Children's and CTI Clinical Trial & Consulting Services.

Key Points: 
  • CINCINNATI, Sept. 20, 2022 /PRNewswire/ --The board of Current Biologics has selected Tom Hochuli as chief executive officer of the startup company, which is focused on providing cell and gene therapy manufacturing and development services to the biotechnology and pharmaceutical industries.
  • Current Biologics was established as a joint venture of Cincinnati Children's and CTI Clinical Trial & Consulting Services.
  • Current Biologics will extend Cincinnati Children's gene therapy expertise to other companies and academic centers.
  • "His expertise will guide Current Biologics as the company recruits talent and builds a state-of-the-art current Good Manufacturing Practice facility capable of producing multiple vectors for cell and gene therapy research.

The Children's Mercy Kansas City Research Institute Pioneers Most-Advanced Genomic Sequencing System in the World

Retrieved on: 
Monday, September 19, 2022
Magnet, YouTube, Faculty, Laboratory, FRS, Twitter, Database, Hospital, Hassenfeld Children's Hospital, NYU Langone Health, Hope, News, LinkedIn, Senior, Degenerative disease, Catholic University of Leuven (1834–1968), Program, Genetics, Preprint, Children's Mercy Hospital, Technology, Instagram, Genetic testing, Mercy, Patient, Family, Doctor of Philosophy, Science, Diagnosis, Research, DNA, Genetic code, Genome, Education, Disease, Antibiotics, Vaccine, Medicine, MD, Child, Kansas City metropolitan area, Facebook, Genomics

KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- The Children's Mercy Kansas City Research Institute announced it has pioneered advances in the human genome using 5-base genomic sequencing that transforms diagnosing and understanding of unsolved pediatric disease.

Key Points: 
  • KANSAS CITY, Mo., Sept. 19, 2022 /PRNewswire/ -- The Children's Mercy Kansas City Research Institute announced it has pioneered advances in the human genome using 5-base genomic sequencing that transforms diagnosing and understanding of unsolved pediatric disease.
  • Thanks to $18.5 million in philanthropic funding, Dr. Pastinen started the Genomic Answers for Kids (GA4K) program at Children's Mercy, a first-of-its-kind pediatric data repository.
  • "The hope that 5-base sequencing offers our families is truly transformative to children not only here in the Kansas City region but across the globe.
  • Visit Children's Mercy and the Children's Mercy Research Institute to learn more, and follow us on Facebook , LinkedIn , Twitter , Instagram and YouTube for the latest news and videos.

Global CBRN (Chemical, Biological, Radiological and Nuclear) Defense Market Report 2022-2026: Military Spending in the Wake of the Russia Ukraine War, CBRN Defense Solutions are Poised to Benefit - ResearchAndMarkets.com

Retrieved on: 
Friday, September 16, 2022
Other Defense, Defense, Radiation, Global, Laboratory, Infection, Plague, Engineering, COVID-19, Smallpox, Risk, Fever Dream, Virus, Role, Good Times, Nature, Chemical substance, Gene, Chemical warfare, Acquisition, Growth, Weapon, Biological warfare, Anthrax, Typhus, CBRN defense, Threat, Program, CBRN, Defense, Technology, Inhalation, Public health, Bacteria, Solution, Human back, Death, Research, DNA, Physics, Biology, Immune system, Genetic code, Chemistry, Spore, CAGR, Pet, Vaccine, Pharmaceutical industry, EU

Biological warfare holds serious concerns as the technology linked with production of these weapons is comparatively affordable and is easy to access.

Key Points: 
  • Biological warfare holds serious concerns as the technology linked with production of these weapons is comparatively affordable and is easy to access.
  • The acquisition along with dissemination of some of the restricted organisms such as Variola major is possible.
  • Russia has alleged that Ukraine and the US are working with pathogens known to cause serious infections in various laboratories.
  • Pandemic Fails to Deter Global Military Spending, Which Spirals to All Time High in 2021, a Sign of Good Times to Prevail for CBRN Defense

Kryptomon to Launch an Exclusive Physital NFT Collection on Binance NFT

Retrieved on: 
Tuesday, September 6, 2022
Diamond, Mickey Hart's Mystery Box, Platinum, Time, Genetic code, Sale, Treasure hunt, Learning, Silver, 2D, NFT, KYC, Diesel, Gold, Matteo Matteazzi, Blockchain, Longevity, Cryptocurrency, Metaverse, Badge, Binance

This launch features one of the world's first Physital NFT collections.

Key Points: 
  • This launch features one of the world's first Physital NFT collections.
  • Meanwhile, the physical asset collection will include a variety of limited-edition exclusive collectibles, each with its unique serial number to prove and verify its authenticity.
  • The main sale will take place on the Binance NFT marketplace exclusively on the 9th of September at 10:00 UTC.
  • Shortly after the exclusive sale on Binance NFT, Kryptomon will launch another exclusive sale on Kryptomon NFT Marketplace in three rounds, for whitelisted wallet addresses only.

University of Miami family of physicians establishes $3 million endowed chair

Retrieved on: 
Friday, August 26, 2022
Partnership, The Miller School of Albemarle, University, Patient, Health equity, Research, CEO, Cancer, Kathleen, Glass, Genetic code, Precision medicine, UM, Volunteering, Physician, Department, Curriculum, Department of Medicine – University of Pamplona, Student, Education, School, GLOBE, Leadership, Movement, Population, Shoe, Leonard M. Miller School of Medicine, University of Miami, Leonard, Health, Family, Jackson, Hospital, Medicine, Medicine, Chenming Hu, Endocrinology

Coral Gables, Fla, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Multiple generations of the Chen family have graduated from the University of Miami and the Leonard M. Miller School of Medicine.

Key Points: 
  • Coral Gables, Fla, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Multiple generations of the Chen family have graduated from the University of Miami and the Leonard M. Miller School of Medicine.
  • The Chen Family Foundation is looking to expand that shared mission even further by donating $3 million to establish the Chen Family Endowed Chair to Advance Primary Care and Health Equity Research.
  • The foresight, leadership, and dedication of Dr. Chris Chen and his family will propel the University forward in our pursuit of health equity, said University of Miami President Julio Frenk.
  • This is why we are investing in the University of Miami, Dr. Chen said.

Kryptomon taps former Diesel merchandising director to head the launch of its "Physital-Wearable"

Retrieved on: 
Monday, August 1, 2022
Knowledge, Cosmetics, Skin, GLOBE, Prada, Diesel, Digital, Learning, Non-fungible token, CEO, Clothing, Meta, Matteo Matteazzi, Blockchain, Genetic code, NFT, Longevity, Toy, Consumer electronics, Metaverse

Digital wearables, skins, and cosmetics have become a vibrant sector for monetization in gaming and online communities, growing into a $40 billion market .

Key Points: 
  • Digital wearables, skins, and cosmetics have become a vibrant sector for monetization in gaming and online communities, growing into a $40 billion market .
  • Just recently, Meta unveiled its partnerships with Prada, Balenciaga, and Thom Browne for their Horizon Worlds marketplace.
  • Following positions as Diesels Global Merchandising Director and Vice President at Calvin Klein Jeans, Matteazzi brings a wealth of knowledge to build the projects launch into the physical NFT ecosystem.
  • Digital wearables have a bright future and show a clear path for NFT longevity, says Davide Matteazzi, Chief Merchandising & Marketplace Officer at Kryptomon.

Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome

Retrieved on: 
Tuesday, July 12, 2022
Technology, Research, Genetics, Other Technology, Software, Biotechnology, Health, Other Science, Science, Borneo, Forest, Technology, Howard Hughes Medical Institute, Bird, Disease, Life, African bush elephant, Multimedia, IUCN, News, Biology, Amphibian, Reptile, Vertebrate Genomes Project, African elephant, Genomics, Risk, Human genome, Fish, Gaps, CEO, Human, Woolly mammoth, Arima, Biodiversity, Elephant, Elephas, Publication, Rockefeller University, Genome, Vertebrate, Health, Mammal, List of life sciences, Genetic code, Climate change, Software, Doctor of Philosophy, DNA, Earth BioGenome Project, Agriculture, Antibiotics, Hunting, VGP, Colossal

Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project (VGP ) have become the first to successfully sequence the entire Asian elephant genome, introducing a new wave of innovative and disruptive animal conservation.

Key Points: 
  • Colossal Biosciences, a breakthrough biosciences and genetic engineering company, and the Vertebrate Genomes Project (VGP ) have become the first to successfully sequence the entire Asian elephant genome, introducing a new wave of innovative and disruptive animal conservation.
  • View the full release here: https://www.businesswire.com/news/home/20220712005534/en/
    Arima Hi-C Assembly of the Asian Elephant (Elephas maximus) Genome.
  • The first phase of this landmark project which was completed in June included the sequencing, assembly, and annotation of the Asian elephant (Elephas maximus) genome.
  • Following the efforts given to the T2T human genome project, the Asian elephant will be one of the first genomes to be sequenced T2T.

MetaWorld Blockchain Receives huge investment from Billionaire Mai Vu Minh

Retrieved on: 
Saturday, July 9, 2022
Efficiency, General game playing, Non-fungible token, Meta, Video, CEO, Syndication, GLOBE, Genetic code, Ecosystem, Health care, Billionaire, Trust, Health, Friction, Cryptocurrency, Digital, Automation, Contract, GAMES, Technology, Blockchain

The executive chairman of the SAPA Thale group, billionaire Mai Vu Minh, said that with Meta World, SAPA Thale aims for "a large digital economy" that will open up right inside the virtual universe under construction.

Key Points: 
  • The executive chairman of the SAPA Thale group, billionaire Mai Vu Minh, said that with Meta World, SAPA Thale aims for "a large digital economy" that will open up right inside the virtual universe under construction.
  • Mai Vu Minh sees the potential of Blockchain use for ensuring supply chain transparency, enabling quick transaction payments, digitalizing art and ensuring data privacy.
  • Using Blockchain can bring unprecedented security, trust, automation and efficiency to almost any type of transaction said Minh.
  • Mai Vu Minh is one of many billionaires investing in Blockchain after realizing the benefits of this technology.